DC Investments Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,636
Closed -$300K 127
2020
Q2
$300K Sell
2,636
-2,485
-49% -$264K 0.11% 209
2020
Q1
$411K Buy
5,121
+1,364
+36% +$141K 0.33% 111
2019
Q4
$401K Sell
3,757
-10
-0.3% -$1.04K 0.31% 161
2019
Q3
$403K Sell
3,767
-1,114
-23% -$114K 0.23% 191
2019
Q2
$497K Sell
4,881
-694
-12% -$66.7K 0.28% 155
2019
Q1
$501K Buy
5,575
+1,634
+41% +$142K 0.32% 150
2018
Q4
$328K Sell
3,941
-1,175
-23% -$110K 0.27% 185
2018
Q3
$552K Sell
5,116
-220
-4% -$24.1K 0.37% 110
2018
Q2
$587K Sell
5,336
-3,743
-41% -$390K 0.37% 72
2018
Q1
$911K Sell
9,079
-737
-8% -$75.5K 0.61% 56
2017
Q4
$967K Buy
+9,816
New +$931K 0.4% 51

Other funds holding DGX

DC Investments Management's DGX Position: Q3 2020 in Review

DC Investments Management sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 2,636 shares — an estimated $300K sold.

DC Investments Management first reported a position in DGX in Q4 2017 and held it in 11 quarters. The position peaked at $967K in Q4 2017. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • DC Investments Management reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • DC Investments Management sold 2,636 Quest Diagnostics shares in Q3 2020, an estimated $300K.
  • DC Investments Management first reported a position in Quest Diagnostics in Q4 2017 and held it in 11 quarters.
  • DC Investments Management's Quest Diagnostics position peaked at $967K in Q4 2017.
  • 757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.